Atgam Injection, Solution
Product Images NDC 0009-7224
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atgam (NDC 0009-7224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (5 mL Ampule Label)
Atgam® is a medication containing lymphocyte immune globulin and anti-thymocyte globulin (equine) with 250 mg protein and 50 mg/mL solution for intravenous use only. Dosage and usage information can be found in the accompanying prescribing information. The medication is manufactured by Pharmacia & Upjohn Co, a division of Pfizer Inc in New York City. The packaging contains NDC 0009-7224-01, 5mL solution, and a caution to use a 0.2 micron to 1.0 micron in-line filter due to the possibility of containing particles. The medication is for Rx only and protected from light. There is an imprint area with a LOT/EXP number and the code PAA165485.*
Principal Display Panel (5–5 mL Ampule Carton)
This is a description of a medicine called Atgam. It comes in a box with 5 single-use ampoules, each containing 5 mL of a sterile solution for intravenous use only. The active ingredient is lymphocyte immune globulin, which is anti-thymocyte globulin made from equine sources. Each ampoule contains 250mg of protein per 5 mL, at a concentration of 50 mg/mL. The product may have a normal granular or flaky deposit. There are infusion instructions included in the product insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.